The Fascinating History of Methylene Blue: From Textile Dye to Modern Medicine

Methylene blue has a history spanning nearly 150 years — from a simple textile dye to a compound that has treated malaria, treated depression, treated cyanide poisoning, treated septic shock, and may treat Alzheimer's disease.

This is the story of one of medicine's most versatile compounds.

1876: The Birth of Methylene Blue

Heinrich Caro, a German chemist working at BASF, first synthesized methylene blue in 1876. It was originally developed as a textile dye for cotton.

The brilliant blue color made it valuable for the dye industry, but it wasn't long before someone noticed its biological properties.

1880s: The First Medical Use

Paul Ehrlich's discovery (1880s):

Paul Ehrlich, the legendary German physician and scientist (who would later win the Nobel Prize in 1908), discovered that methylene blue could stain specific cells and bacteria. This led to:

· **Bacteriological staining** — visualizing bacteria for the first time

· **Cell biology** — understanding cell structure

· **Malaria treatment** — Ehrlich and others found methylene blue effective against malaria

Methylene blue was the first synthetic drug used to treat malaria — a treatment that saved countless lives before modern antimalarials.

1890s–1900s: Discovery of Antimalarial Properties

Guttmann and Ehrlich (1891):

· Documented methylene blue's effectiveness against malaria

· One of the first effective malaria treatments

· Used in World War I to prevent malaria in soldiers

Why it worked: Methylene blue interferes with heme detoxification in the malaria parasite.

The mechanism is still used in modern research — methylene blue derivatives are being explored as novel antimalarials.

Early 20th Century: Multiple Discoveries

As the 20th century began, researchers discovered more properties:

1899: Antiseptic properties

· Used in wound care

· Antiseptic for urinary tract infections

· Treatment for gonorrhea (topical)

1900s: Neurological effects

· Animal studies showed neurological effects

· Sedative properties observed

· Used experimentally in various psychiatric conditions

1920s–1930s: Psychiatric use

· Used in clinical psychiatry for various conditions

· Schizophrenia treatment attempts (limited success)

· Mood disorder observations

1950s: The MAOI Connection

The breakthrough that changed psychiatry:

In the 1950s, researchers discovered that methylene blue was a monoamine oxidase (MAO) inhibitor.

This discovery was pivotal:

· Led to the development of the first MAOI antidepressants

· Iproniazid (a TB drug) was found to be an MAOI

· Followed by isoniazid and the classic MAOIs (Nardil, Parnate, etc.)

· Foundation of modern psychopharmacology

Methylene blue was the parent compound of this entire class of antidepressants.

1960s–1980s: Antibacterial and Antimicrobial Research

Methylene blue light therapy:

· Discovered to have photodynamic antimicrobial properties

· Used in blood product sterilization (eliminating viruses and bacteria)

· Plasmodium inactivation in blood donations (still used)

Cancer research:

· Photodynamic therapy for cancer (using light + methylene blue)

· Research on tumor imaging

· Some clinical use in specific cancers

Diagnostic uses:

· Sentinel lymph node mapping

· Endoscopic visualization

· Surgical site identification

1990s: The Tau Connection

The Alzheimer's breakthrough:

In 1996, Claude Wischik's group at the University of Aberdeen discovered that methylene blue could:

· Bind to tau protein

· Inhibit tau aggregation

· Disassemble existing tau tangles

This launched modern methylene blue research and eventually led to the development of TRx0237 (LMTX) by TauRx Therapeutics.

2000s: Mitochondrial Renaissance

Research exploded on methylene blue's mitochondrial properties:

· Alternative electron carrier

· Mitochondrial protection

· Antioxidant effects

· Neuroprotection in various models

Biohacking community discovered it:

· Internet forums popularized low-dose use

· Reddit, LessWrong, and other communities shared experiences

· "Smart drug" reputation grew

· Serious research interest followed

2010s: Clinical Trials and Biohacking Boom

TauRx trials:

· Phase II trial showed benefits

· Phase III trials had mixed results

· Subgroup analyses suggested monotherapy benefits

· Continued development

Biohacking popularity:

· Methylene blue became a popular nootropic

· "Methylene blue Monday" memes

· "Blue brain" trend

· Many users, mixed experiences

· Safety concerns raised by medical community

Septic shock research:

· Increased use in critical care

· Multiple trials and meta-analyses

· Established as rescue therapy

COVID-19 pandemic:

· Used in some severe COVID cases

· Limited evidence, mixed results

· Renewed interest in anti-inflammatory and antiviral properties

2020s: Cutting-Edge Research

Current research areas:

1. Alzheimer's disease

· TRx0237 in clinical trials

· Combination therapies

· Earlier intervention focus

· Biomarker-guided treatment

2. Parkinson's disease

· Animal model protection

· Pilot human studies

· Combination with existing therapies

3. ALS

· Mitochondrial protection

· Pilot trials

4. Aging and longevity

· Mitochondrial biogenesis

· Cellular senescence

· Healthspan extension

5. Mitochondrial diseases

· Specific genetic conditions

· Rare disease applications

6. Cancer

· Photodynamic therapy refinements

· Combination with immunotherapy

· Tumor microenvironment modulation

Why the Long History Matters

1. Long safety record

· Used in medicine for 130+ years

· Well-characterized in clinical settings

· Known drug interaction profile

2. Multiple mechanisms

· Validated across many conditions

· Multi-target approach attractive for complex diseases

· Adaptogenic properties (different effects at different doses)

3. Active research

· Not a "dead" compound

· New research published regularly

· Clinical trials ongoing

4. Established manufacturing

· Pharmaceutical-grade available

· Quality control established

· Cost-effective

The Ethical History

Methylene blue's history also includes some darker chapters:

· **WWI and WWII:** Used to treat malaria in soldiers

· **Concentration camps:** Paul Ehrlich's work was used in some ethically problematic ways (Ehrlich himself was not directly involved in Nazi-era research)

· **Colonial medicine:** Used in colonial tropical medicine

· **Syphilis treatment:** Used before penicillin era

The lesson: All of modern medicine has complex ethical histories. Methylene blue's research legacy is mixed but the compound has saved millions of lives through its antimalarial and other uses.

The Modern Reincarnation

Today's methylene blue exists in three main contexts:

1. Pharmaceutical medicine

· Methemoglobinemia (FDA-approved)

· Hospital use for vasoplegia, septic shock

· Ifosfamide toxicity prevention

2. Clinical trials

· TRx0237 for Alzheimer's and FTD

· Other trials ongoing

· Research applications

3. Biohacker/nootropic community

· Low-dose supplement use

· Self-experimentation

· Mixed experiences, real safety concerns

Each context has different risk-benefit profiles and should be evaluated separately.

The Future

Predictions for the next decade:

· Refined Alzheimer's trials with better patient selection

· More combination therapies (methylene blue + other treatments)

· Better understanding of optimal dosing

· Possibly new FDA approvals for specific conditions

· Continued biohacking community use

· More data on longevity applications

One thing is certain: After 150 years, methylene blue continues to surprise researchers and clinicians. Its unique properties — particularly the mitochondrial effects — make it relevant to many of modern medicine's most challenging problems.

FAQ

Is methylene blue still used in medicine today?

Yes, regularly. Most commonly for methemoglobinemia and septic shock/vasoplegia in hospital settings.

Who discovered methylene blue?

Heinrich Caro at BASF in 1876 (synthesis). Paul Ehrlich discovered its medical applications in the 1880s.

Has methylene blue been used in wars?

Yes — to prevent and treat malaria in soldiers from WWI onwards.

Is methylene blue the first synthetic drug?

It's often called that — it was the first fully synthetic compound used as a drug.

Why was methylene blue less popular before?

Better, safer drugs were developed for most conditions. Its renaissance is due to new understanding of its mechanisms (especially mitochondrial).

Are there books about methylene blue?

Yes — including scientific reviews and history of medicine texts. It's a fascinating case study in pharmacology.

Conclusion

The story of methylene blue is a microcosm of modern medicine's evolution — from accidental discovery to intentional drug development, from single use to multiple applications, from one era's wonder drug to the next's research tool.

Key lessons from its history:

· Drug discovery is often serendipitous

· Old compounds can find new uses

· Safety profiles become clearer over time

· The same compound can be appropriate in some contexts and inappropriate in others

· Long history is both a strength (established data) and limitation (older compounds may have been superseded)

For most people, methylene blue's history is interesting context but doesn't change the practical safety considerations. Use it only when and how it's appropriate (typically under medical supervision).

For a broader perspective on evidence-based supplementation, our Antioxidant Support Stack provides well-studied alternatives for cellular protection.